|
1
|
Djebali S, Davis CA, Merkel A, Dobin A,
Lassmann T, Mortazavi A, Tanzer A, Lagarde J, Lin W, Schlesinger F,
et al: Landscape of transcription in human cells. Nature.
489:101–108. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Martens-Uzunova ES, Böttcher R, Croce CM,
Jenster G, Visakorpi T and Calin GA: Long noncoding RNA in
prostate, bladder, and kidney cancer. Eur Urol. 65:1140–1151. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Ponting CP, Oliver PL and Reik W:
Evolution and functions of long noncoding RNAs. Cell. 136:629–641.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Zhou S, Wang J and Zhang Z: An emerging
understanding of long noncoding RNAs in kidney cancer. J Cancer Res
Clin Oncol. 140:1989–1995. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Fang Z, Wu L, Wang L, Yang Y, Meng Y and
Yang H: Increased expression of the long non-coding RNA UCA1 in
tongue squamous cell carcinomas: A possible correlation with cancer
metastasis. Oral Surg Oral Med Oral Pathol Oral Radiol. 117:89–95.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Gao W, Chan JY and Wong TS: Long
non-coding RNA deregulation in tongue squamous cell carcinoma.
BioMed Res Int. 2014:4058602014. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Shi X, Sun M, Liu H, Yao Y and Song Y:
Long non-coding RNAs: A new frontier in the study of human
diseases. Cancer Lett. 339:159–166. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Yoshimoto R, Mayeda A, Yoshida M and
Nakagawa S: MALAT1 long non-coding RNA in cancer. Biochim Biophys
Acta. 1859:192–199. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Liu S, Song L, Zeng S and Zhang L:
MALAT1-miR-124-RBG2 axis is involved in growth and invasion of
HR-HPV-positive cervical cancer cells. Tumour Biol. 37:633–640.
2016. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Feng T, Shao F, Wu Q, Zhang X, Xu D, Qian
K, Xie Y, Wang S, Xu N, Wang Y, et al: miR-124 downregulation leads
to breast cancer progression via LncRNA-MALAT1 regulation and
CDK4/E2F1 signal activation. Oncotarget. 7:16205–16216.
2016.PubMed/NCBI
|
|
11
|
Reedijk M, Odorcic S, Chang L, Zhang H,
Miller N, McCready DR, Lockwood G and Egan SE: High-level
coexpression of JAG1 and NOTCH1 is observed in human breast cancer
and is associated with poor overall survival. Cancer Res.
65:8530–8537. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Chang WH, Ho BC, Hsiao YJ, Chen JS, Yeh
CH, Chen HY, Chang GC, Su KY and Yu SL: JAG1 is associated with
poor survival through inducing metastasis in lung cancer. PLoS One.
11:e01503552016. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Selcuklu SD, Donoghue MT, Kerin MJ and
Spillane C: Regulatory interplay between miR-21, JAG1 and
17beta-estradiol (E2) in breast cancer cells. Biochem Biophys Res
Commun. 423:234–239. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Liu MX, Siu MK, Liu SS, Yam JW, Ngan HY
and Chan DW: Epigenetic silencing of microRNA-199b-5p is associated
with acquired chemoresistance via activation of JAG1-Notch1
signaling in ovarian cancer. Oncotarget. 5:944–958. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
An L, Liu Y, Wu A and Guan Y: microRNA-124
inhibits migration and invasion by down-regulating ROCK1 in glioma.
PLoS One. 8:e694782013. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Wang X, Liu Y, Liu X, Yang J, Teng G,
Zhang L and Zhou C: miR-124 inhibits cell proliferation, migration
and invasion by directly targeting SOX9 in lung adenocarcinoma.
Oncol Rep. 35:3115–3121. 2016.PubMed/NCBI
|
|
17
|
Han G, Wang Y, Bi W, Jia J and Wang W:
MicroRNA-124 functions as a tumor suppressor and indicates
prognosis in human osteosarcoma. Exp Ther Med. 9:679–684.
2015.PubMed/NCBI
|
|
18
|
Zheng F, Liao YJ, Cai MY, Liu YH, Liu TH,
Chen SP, Bian XW, Guan XY, Lin MC, Zeng YX, et al: The putative
tumour suppressor microRNA-124 modulates hepatocellular carcinoma
cell aggressiveness by repressing ROCK2 and EZH2. Gut. 61:278–289.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Liu K, Zhao H, Yao H, Lei S, Lei Z, Li T
and Qi H: MicroRNA-124 regulates the proliferation of colorectal
cancer cells by targeting iASPP. BioMed Res Int.
2013:8675372013.PubMed/NCBI
|
|
20
|
Gutschner T, Hämmerle M and Diederichs S:
MALAT1 - a paradigm for long noncoding RNA function in
cancer. J Mol Med (Berl). 91:791–801. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Hirata H, Hinoda Y, Shahryari V, Deng G,
Nakajima K, Tabatabai ZL, Ishii N and Dahiya R: Long noncoding RNA
MALAT1 promotes aggressive renal cell carcinoma through Ezh2 and
interacts with miR-205. Cancer Res. 75:1322–1331. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Yang MH, Hu ZY, Xu C, Xie LY, Wang XY,
Chen SY and Li ZG: MALAT1 promotes colorectal cancer cell
proliferation/migration/invasion via PRKA kinase anchor protein 9.
Biochim Biophys Acta. 1852:166–174. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Xiao H, Tang K, Liu P, Chen K, Hu J, Zeng
J, Xiao W, Yu G, Yao W, Zhou H, et al: LncRNA MALAT1 functions as a
competing endogenous RNA to regulate ZEB2 expression by sponging
miR-200s in clear cell kidney carcinoma. Oncotarget. 6:38005–38015.
2015.PubMed/NCBI
|
|
24
|
Wang X, Li M, Wang Z, Han S, Tang X, Ge Y,
Zhou L, Zhou C, Yuan Q and Yang M: Silencing of long noncoding RNA
MALAT1 by miR-101 and miR-217 inhibits proliferation, migration,
and invasion of esophageal squamous cell carcinoma cells. J Biol
Chem. 290:3925–3935. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Xie C, Han Y, Liu Y, Han L and Liu J:
miRNA-124 down-regulates SOX8 expression and suppresses cell
proliferation in non-small cell lung cancer. Int J Clin Exp Pathol.
7:6534–6542. 2014.PubMed/NCBI
|
|
26
|
Cheng Y, Li Y, Nian Y, Liu D, Dai F and
Zhang J: STAT3 is involved in miR-124-mediated suppressive effects
on esophageal cancer cells. BMC Cancer. 15:3062015. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Taniguchi K, Sugito N, Kumazaki M,
Shinohara H, Yamada N, Matsuhashi N, Futamura M, Ito Y, Otsuki Y,
Yoshida K, et al: Positive feedback of DDX6/c-Myc/PTB1 regulated by
miR-124 contributes to maintenance of the Warburg effect in colon
cancer cells. Biochim Biophys Acta. 1852:1971–1980. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Hunt S, Jones AV, Hinsley EE, Whawell SA
and Lambert DW: MicroRNA-124 suppresses oral squamous cell
carcinoma motility by targeting ITGB1. FEBS Lett. 585:187–192.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Simon DP, Giordano TJ and Hammer GD:
Upregulated JAG1 enhances cell proliferation in adrenocortical
carcinoma. Clin Cancer Res. 18:2452–2464. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Dickson BC, Mulligan AM, Zhang H, Lockwood
G, O'Malley FP, Egan SE and Reedijk M: High-level JAG1 mRNA and
protein predict poor outcome in breast cancer. Mod Pathol.
20:685–693. 2007. View Article : Google Scholar : PubMed/NCBI
|
